HCA Healthcare, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.0% | +3.1% | +8.4% | +7.1% | +14.9% | +5.4% | +6.8% | +3.3% | +7.2% | +5.9% | +2.0% | |
| – | +3.4% | -1.6% | +9.8% | +2.4% | +9.6% | +10.2% | +9.8% | +0.7% | +9.4% | +10.0% | -17.4% | |
| – | +30.9% | -12.8% | +13.3% | -31.4% | +23.7% | +188.7% | -19.1% | -37.4% | +3.0% | +106.7% | -46.2% | |
| – | +30.9% | -12.8% | +13.3% | -31.4% | +23.7% | +188.7% | -19.1% | -37.4% | +3.0% | +116.1% | -48.5% | |
| – | +3.4% | -1.1% | +11.6% | +4.4% | +8.7% | -4.5% | +14.8% | +9.8% | +12.0% | +8.0% | +1.1% | |
| – | +12.5% | +4.4% | +4.7% | +10.1% | +6.8% | +9.5% | -1.9% | +4.1% | -2.3% | -14.0% | -4.9% | |
| – | +4.6% | +8.9% | +9.4% | +10.4% | +15.0% | +2.1% | +12.8% | +5.6% | +8.3% | +5.4% | +5.5% | |
| – | +5.3% | -0.1% | +11.1% | +8.2% | +4.3% | +3.4% | +11.3% | +1.7% | +3.4% | +1.7% | +5.2% | |
| – | -1.5% | -4.8% | -4.0% | -4.7% | -3.5% | +11.8% | +9.2% | -10.9% | -5.6% | -4.7% | +3,086.7% | |
| – | +2.9% | +1.5% | +5.6% | +1.3% | +8.3% | -2.2% | +10.4% | +6.6% | +5.0% | +6.9% | +7.7% | |
| – | +0.7% | +5.8% | +5.6% | +22.9% | +2.5% | +12.2% | +10.1% | +3.3% | +27.8% | +19.9% | +7.7% | |
| – | -31.1% | -7.3% | -7.4% | +294.0% | -37.2% | +18.8% | +7.0% | +16.7% | +279.7% | +80.9% | +4.0% | |
| – | +6.6% | +6.8% | +12.4% | -1.1% | +12.7% | +21.7% | +16.3% | +3.1% | -0.1% | +1.0% | +9.0% | |
| – | +3.2% | +3.0% | +5.4% | -2.5% | +4.8% | -8.3% | +11.5% | +9.8% | -1.4% | +3.1% | +8.5% | |
| – | – | – | – | – | – | – | -48.5% | -104.9% | – | -47.6% | -599.3% | |
| – | – | – | – | – | – | – | -168.5% | – | – | – | – | |
| – | -5.2% | -7.2% | -6.0% | -4.5% | -2.0% | -0.8% | -4.8% | -10.4% | -6.2% | -5.3% | -11.9% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.